Michael Ryskin
Stock Analyst at B of A Securities
(0)
# 4269
Out of 5,325 analysts
43
Total ratings
46.43%
Success rate
-11.99%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MRVI Maravai LifeSciences | Maintains: Buy | 9 8 | 2.11 | 279.15% | 3 | Mar 3, 2025 | |
TEM Tempus AI | Maintains: Neutral | 54 60 | 49.58 | 21.02% | 4 | Mar 3, 2025 | |
IDXX IDEXX Laboratories | Maintains: Neutral | 475 535 | 427.18 | 25.24% | 2 | Feb 4, 2025 | |
ALGN Align Tech | Maintains: Underperform | 200 206 | 177.39 | 16.13% | 6 | Dec 13, 2024 | |
GH Guardant Health | Maintains: Strong Buy | 28 40 | 45.67 | -12.42% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 10 | 5.07 | 87.38% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 9 | n/a | n/a | 2 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 14.26 | 68.3% | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 15.5 | 54.84% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 25 | 23.99 | 4.21% | 2 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 225 180 | 150.99 | 19.21% | 7 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 90 | 20.01 | 349.78% | 3 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 52 | 25.5 | 103.92% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 17 10 | 3.21 | 211.53% | 2 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 10 7 | 0.07 | 9900% | 2 | May 14, 2020 |